✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)
BIOGROUP NORD
SAS · Active since 2008
Overview
BIOGROUP NORD is a simplified joint-stock company registered in villeneuve-d-ascq, France, since 2008. With reported revenue of 38.5M EUR in 2023. Its TraceComp score of 85 (A) indicates solid fundamentals and low apparent risk. With 17 years of operations, the company has an established track record in its market.
Company Information
- Registration Number
- 507815942
- Legal Form
- SAS
- Registered
- 2008-08-01
- Address
- villeneuve-d-ascq
Financial Profile
Latest filed accounts: FY 2023 · most recent available in public filings
Multi-year financials & ratios
5 years of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Officers & Management
16 officers/directors on file — names, roles, appointment & resignation dates.
| Name | Role | Status |
|---|---|---|
| THIERRY BLARINGHEM | Directeur Général | Current |
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Public Contracts Won
Awarded 3 public-sector contracts totalling EUR 342,000 (DECP).
Which public buyers, contract titles, values and award dates.
What’s in the full report
- Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
- Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
- Insolvency & legal events — collective proceedings and adverse filings (where on record)
- Charges & secured lending — registered charges and the creditors entitled (where filed)
- Sanctions & screening — company-level watchlist & adverse signals
- Sector benchmark & peers — how the company compares to its sector and nearest peers
- Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Risk Signals
No adverse legal events have been recorded for this company.
- Revenue down 16% year-on-year
- Profitable: positive net income in FY 2023
- Altman Z-Score in the safe zone
Similar Companies
Data Sources & Freshness
Data sourced from: official public registries.